]>
IRCT20120104008611N13 IRCT 2022-04-05 Tehran University of Medical Sciences Relationship between beta gonadotropin and pregnancy outcome in the in vitro fertilization cycle Correlation between beta Human chorionic gonadotropin (β-Hcg) on day ۱۴ after embryo transfer and pregnancy outcome in IVF cycles 2022-03-16 anticipated 177 Complete https://irct.ir/trial/62179 interventional Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Treatment. 3 Female Infertility. Intervention group: Receiving estradiol 6 mg daily on the second or third day of the menstrual cycle, then after reaching a thickness of 8 mm endometrium, receiving 50 mg progesterone ampoule twice a day for three days until embryo transfer. Yes - There is a plan to make this available What will be shared: The collected information is in the form of a questionnaire and is statistically analyzed. When: The start of the access period is one year after the results are published To whom: For obstetricians and researchers working in academic institutions Conditions: Evaluate the path and process of study and analyze it Where to obtain: For information, refer to Dr. Hamideh Pakniat. The communication channels are as follows: By sending an email to the address: hpakniat@qums.ac.ir or refer and contact Kosar Hospital at the address: Taleghani St, Qazvin. Phone: 028-33236374 Postal address: 34156-13176 How to obtain: After sending the e-mail, the requested information will be reviewed by the facilitator and the person responsible for the scientific response of the study. At your discretion, the requested information will be sent within 10 days after receiving the email. Comments:
public Hamideh Pakniat
Kosar Hospital, Taleghani St., Qazvin
Qazvin Iran (Islamic Republic of) 13176- 34156 +98 28 3323 6374 hpakniat@qums.ac.ir Qazvin University of Medical Sciences scientific Hamideh Pakniat
Kosar Hospital, Taleghani St., Qazvin
Qazvin Iran (Islamic Republic of) 13176- 34156 +98 28 3323 6374 hpakniat@qums.ac.ir Qazvin University of Medical Sciences Iran (Islamic Republic of) Body mass index below 30 Age between 20 to 42 years Have at least 3 grade A or B embryos All ladies with fresh or frozen transitions Above 25 Beta Hatch CG number on day 14 20 years 42 years Female Uterine anomaly Submucosal myoma Endometrial polyps Existence of chronic diseases (such as cardiovascular) Use of group D and X drugs during pregnancy N97 Female infertility Treatment - Drugs Intervention group: Receiving estradiol 6 mg daily on the second or third day of the menstrual cycle, then after reaching a thickness of 8 mm endometrium, receiving 50 mg progesterone ampoule twice a day for three days until embryo transfer Assess endometrial thickness. Timepoint: The second or third day of the menstrual cycle. Method of measurement: Using an ultrasound machine. The estradiol level. Timepoint: At the beginning of the study until the endometrial thickness reaches 8 mm. Method of measurement: Blood sample. Biochemical pregnancy. Timepoint: Once, 14 days after fetus transfer. Method of measurement: Blood sampling. Clinical pregnancy. Timepoint: Once, 6 to 8 weeks after embryo transfer. Method of measurement: Observation of pregnancy sac and heart rate on ultrasound. Tehran University of Medical Sciences Approved 2021-10-31 Ethics Committee of the Faculty of Medical Sciences and Health Services, University of Tehran Tehran University of Medical Sciences, Central Building, Ghods Ave., Keshavarz Blvd. Tehran Tehran Iran (Islamic Republic of)